#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Small cell lung cancer recurrent Inclusion body myositis Immunodeficiency common variable Pancreatic neuroendocrine tumour Phenylketonuria Giant cell tumour of tendon sheath Central nervous system neoplasm Corneal neovascularisation Colitis ulcerative Breast cancer Mucous membrane pemphigoid Atopic keratoconjunctivitis Mycobacterium abscessus infection Pemphigoid Spinal cord injury More trials…

    Learn about Rare Diseases

    Metachromatic leukodystrophy – Basic Information CADASIL – Treatment Small intestine leiomyosarcoma – Basic Information Acute respiratory distress syndrome – Life with Disease MELAS syndrome – Basic Information Mantle cell lymphoma stage II – Basic Information Angelman’s syndrome Isodicentric chromosome 15 syndrome – Basic Information Haemophilia – Basic Information Mantle cell lymphoma stage II – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abatacept Cebsulfase Alfa Ciltacabtagene Autoleucel Levoleucovorin Ceftolozane Teriflunomide Meropenem Anhydrous Iph6501 Itraconazole Calcium Chloride Quizartinib Dihydrochloride Tapderimotide Acetazolamide Sodium Follitropin Alfa Venlafaxine Hydrochloride Topotecan Hydrochloride Amniotic Membrane, Human Propafenone Hydrochloride GSKVX000000046019 Diphenhydramine More therapies…

    Learn about Your Condition

    Obstructive airways disorder Craniosynostosis Biotinidase deficiency Nicotine dependence Milk allergy Lichen planopilaris Lymphangiosarcoma Cartilage injury Anal cancer Chondrocalcinosis Vascular malformation Syphilis Liver transplant Breast cancer stage III Biliary neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Congenital, Hereditary, and Neonatal Diseases and Abnormalities

  • Study on Allopurinol Sodium for Brain Injury Prevention in Newborns with Critical Congenital Heart Disease Undergoing Heart Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Brain injury
    • Heart disease congenital
    Investigated Drugs:
    • Allopurinol Sodium
    The Netherlands
  • Study on the Use of Human Apotransferrin for Treating Patients with Atransferrinemia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Blood iron increased
    • Congenital hypotransferrinaemia
    • Hypochromic anaemia
    Investigated Drugs:
    • Human Apotransferrin
    Germany Italy Spain
  • Long-Term Safety and Efficacy Study of Eplontersen in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Eplontersen
    Cyprus France Germany Italy Portugal Spain +1
  • Study on Hydroxycarbamide Tablets for Children with Sickle Cell Disease

    Recruiting

    2 1 1
    Investigated Drugs:
    • Hydroxycarbamide
    France
  • Study on Sedation Effects of Dexmedetomidine vs. Midazolam in Mechanically Ventilated Preterm Infants

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Midazolam
    France
  • Study on the Safety and Effects of Infusing Modified CD34+ Cells for Patients with Fanconi Anemia Subtype A

    Recruiting

    1 1 1
    Investigated Diseases:
    • Congenital aplastic anaemia
    Investigated Drugs:
    • Autologous Cd34+Enriched Cells From Patients With Fanconi Anemia Subtype A Transduced Ex Vivo With Lentiviral Vector Carrying The Fanconi Anemia Complementation Group A Gene
    Spain
Previous Page
1 … 8 9 10 11 12 … 45
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!